Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
EP4 is a G protein-coupled receptor for prostaglandin E2 (PGE2), a key lipid mediator involved in inflammation and various physiological processes. It is considered therapeutically promising due to its broad range of biological effects, including roles in inflammation, vascular function, thrombosis, cancer, and bone metabolism. Its diverse functions are context-dependent, with potential for both beneficial and detrimental effects.
Activation of Gs proteins leading to increased cAMP levels and subsequent activation of PKA, PI3K/AKT/mTOR, and ERK/MAPK pathways; inhibition of NF-kB activation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on E-type Prostanoid Receptor 4 (EP4).